Chinese drug shows promise against Nipah virus in study

CBD-Rich Cannabis Extracts Reduce ADHD Symptoms in Children With Autism

Global pharmacovigilance analysis of classic psychedelics and MDMA reveals that while psychiatric adverse events are frequent in real-world settings, severe physical complications remain rare

Dharma: A novel, clinically grounded machine learning framework for pediatric appendicitis—Diagnosis, severity assessment and evidence-based clinical decision support

A staph aureus protein is engineered to target and deliver toxins into cancer cells

Maternal flu, Tdap vaccination cuts risk of infant hospitalization, ED visits by 70% to 89%, study finds

Clinical Trial: CBD Not Associated With Liver Abnormalities

Clinical Trial: Plant-Derived Cannabis Formulations Show Comparable Efficacy to Lorazepam in Insomnia Patients

Stress early in life increases long-term cardiovascular disease risk

A Phase 1 trial reports that the oral drug TLC-2716 cuts triglycerides by 38% and remnant cholesterol by 61%

Study of 4.5 years of prescription records from 12,000 adults with depression finds that higher genetic risk for bipolar disorder, ADHD, neuroticism, and depression creates a more difficult-to-treat form of depression

Open-Source Autonomous AI Agents Developed to Detect Early Signs of Cognitive Decline

Early trial of Nipah virus vaccine shows promise

Global Analysis Reveals Sharp Rise in Cancer Among People Under 50

A battle over Canada’s mystery brain disease

After sibling analysis, acid-suppressing medications did not link with autism, ADHD, or OCD

High-dose risankizumab induces rapid, deep skin clearance in moderate-to-severe psoriasis and sustains remission long after treatment stops, alongside a significant reduction in pathogenic tissue-resident memory T cells within former lesions, supporting its potential as a durable therapeutic option.

Researchers found that "evening people" were 79% more likely to have poor overall heart health, with higher risk for heart attack and stroke, compared with those in the "intermediate" group

Pharmacoepidemiology of Oxycodone in the USA: An Observational Study of ARCOS, Medicaid, and Medicare Drug Databases: Study finds peak distribution in 2010 but also pronounced state-level disparities.

Clinical Trial: Cannabis Topicals Mitigate Pain, Improve Physical Functioning in Breast Cancer Patients

Microdosing psychedelics linked to better sleep and exercise habits

A drug once designed for dengue virus, then quietly abandoned by industry, is suddenly back in the spotlight

Updated Comprehensive Review finds that methylphenidate may reduce ADHD symptoms (inattention, hyperactivity) in children/adolescents, but evidence certainty is low

Ants may be ahead of humans in antibiotic innovation

Injectable antibodies in nanoparticles could replace hour-long infusions: A much faster, simpler treatment without an IV bag and an hour of getting needled

Bath salts trigger damaging surges of Reactive Oxygen Species (ROS) that drive heart cell demise

The U.S. Is Funding Fewer Grants in Every Area of Science and Medicine

Brainstem dysfunction as a potential etiology of ME/CFS and long COVID: A mechanical basis

Air pollution is a significant environmental determinant of the cardiovascular-kidney-metabolic (CKM) syndrome

Hearing loss is associated with Reactive Oxygen Species (ROS)

More →